investigation the effective of oral amoxicillin with half the therapeutic dose in reducing the hospitalization rate of patients with neuromuscular disease and cerebral palsy due to aspiration pneumonia during the years 1401-1402

Not Applicable

Recruiting

• Conditions: Condition 1: Aspiration Pneumonia. Condition 2: Cerebral Palsy.; Pneumonitis due to solids and liquids; Cerebral palsy

• Registration Number: IRCT20221126056619N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 June 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients aged between 6 months to 15 years suffering from severe neurological diseases and cerebral palsy undergoing related neurological treatments.
Patients who have presented with recurrent respiratory infections and have a previous history of at least one hospitalization due to aspiration pneumonia.
Patients who have been evaluated for demographic conditions, socioeconomic level, oral and dental nutrition status, care hygiene, cognitive status, movement and musculoskeletal conditions, and respiratory conditions, including dependence on respiratory devices.

Exclusion Criteria

Patients who do not tolerate the oral antibiotic (Amoxicillin) treatment or show gastrointestinal symptoms will be excluded from the study.
Any severe illness or medical condition that, in the opinion of the investigator, might interfere with the patient's participation in the study.

Study & Design

• Study Type: interventional
• Study Design: Not specified